A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
-32.69%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$110M
AUM Growth
+$110M
Cap. Flow
+$3.67M
Cap. Flow %
3.33%
Top 10 Hldgs %
94.25%
Holding
17
New
1
Increased
–
Reduced
2
Closed
1

Top Buys

1
SLNO icon
Soleno Therapeutics
SLNO
$7.98M

Top Sells

1
CRSP icon
CRISPR Therapeutics
CRSP
$1.88M
2
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
$1.32M
3
CBAY
Cymabay Therapeutics
CBAY
$1.12M

Sector Composition

1 Healthcare 99.58%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.71B
$33.5M 30.41%
1,171,268
-65,934
-5% -$1.88M
SIEN
2
DELISTED
Sientra, Inc.
SIEN
$28M 25.42%
2,199,012
– –
VRNA
3
Verona Pharma
VRNA
$9.16B
$8.12M 7.38%
901,943
– –
SLNO icon
4
Soleno Therapeutics
SLNO
$3.6B
$7.98M 7.25%
+4,669,272
New +$7.98M
CHMA
5
DELISTED
Chiasma, Inc. Common Stock
CHMA
$6.1M 5.54%
2,080,595
– –
OBSV
6
DELISTED
ObsEva SA Ordinary Shares
OBSV
$5.57M 5.06%
440,000
– –
PRTK
7
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5.34M 4.85%
1,041,131
– –
TARA icon
8
Protara Therapeutics
TARA
$120M
$4.58M 4.16%
2,017,872
– –
AUPH icon
9
Aurinia Pharmaceuticals
AUPH
$1.58B
$2.72M 2.47%
400,434
– –
SRRA
10
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.89M 1.72%
1,444,445
– –
CLLS
11
Cellectis
CLLS
$258M
$1.66M 1.51%
100,000
– –
RARE icon
12
Ultragenyx Pharmaceutical
RARE
$2.89B
$1.66M 1.5%
38,100
– –
ADAP
13
Adaptimmune Therapeutics
ADAP
$15.6M
$1.44M 1.31%
250,000
– –
CBAY
14
DELISTED
Cymabay Therapeutics
CBAY
$1.03M 0.94%
131,036
-142,381
-52% -$1.12M
IMDZ
15
DELISTED
Immune Design Corp.
IMDZ
$458K 0.42%
352,300
– –
OCGN icon
16
Ocugen
OCGN
$319M
$77K 0.07%
888,889
– –
AVEO
17
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-400,000
Closed -$1.32M